GAD65 and insulin B chain peptide (9-23) are not primary autoantigens in the type 1 diabetes syndrome of the BB rat

Autoimmunity

Volumn 31, Issue 1, 1999, Pages 15-24

  Bieg, S ^b   Hanlon, C ^a   Hampe, C S ^b   Benjamin, D ^a   Mahoney, C P ^a  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

GAD65; GAD65 antibody; GAD65 p35; Immunization; Insulin B chain peptide (9 23); Tolerization; Type 1 diabetes

Indexed keywords

AUTOANTIGEN; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE; INSULIN; INTERLEUKIN 10; ISOENZYME; MESSENGER RNA; PROTEIN P35; ANTIBODY; AUTOANTIBODY; CYTOKINE; GLUTAMATE DECARBOXYLASE 65; INSULIN B (9 23); INSULIN B (9-23); PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BETA CHAIN; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; EPITOPE MAPPING; GENE EXPRESSION; IMAGE ANALYSIS; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN SITU HYBRIDIZATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; ONSET AGE; PATHOGENESIS; PREVALENCE; RADIOIMMUNOASSAY; RAT; T LYMPHOCYTE; THYMUS; THYROIDITIS; ANIMAL; BIOBREEDING RAT; BLOOD; GENETICS; HUMAN; IMAGE PROCESSING; IMMUNOLOGY; METABOLISM; PATHOLOGY;

AGE OF ONSET; ANIMALS; ANTIBODIES; AUTOANTIBODIES; AUTOANTIGENS; CYTOKINES; DIABETES MELLITUS, TYPE 1; GLUTAMATE DECARBOXYLASE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNIZATION; IN SITU HYBRIDIZATION; INSULIN; ISOENZYMES; PEPTIDE FRAGMENTS; RADIOIMMUNOASSAY; RATS; RATS, INBRED BB; RECOMBINANT PROTEINS; THYMUS GLAND;

EID: 0033233474     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939908993855     Document Type: Article

References (36)

1. E.H. Leiter and R.G. Gill, Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. J. Endocrinol. Invest. 1994, 17: 595-599.
2. B. Charlton, E.-C. Taylor, R. Tisch and C.G. Fathtman. Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice. J. Autoimmunity 1994, 7: 549-560.
3. J.F. Bach. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 1994, 15: 516-542.
4. Å. Lernmark. Immune surveillance: Paraneoplastic or environmental triggers of autoimmunity. Crit. Rev. Immunol. 1997, 17: 437-447.
5. V.K. Ramiya, M.S. Lan, C.H. Wasserfall, A.L. Notkins and N.K. Maclaren. Immunization therapies in the prevention of diabetes. J. Autoimmunity 1997, 10: 287-292.
6. H. Xie, B.W. Zhang, Y. Matsumoto, Q. Li, A.L. Notkins and M.S. Lan. Autoantibodies to IA-2 and IA-2 beta in insulin-dependent diabetes mellitus recognize conformational epitopes - Location of the 37-and 40-kDa fragments determined. J. Immunol. 1997, 159: 3662-3667.
7. H.J. Aanstoot, S.M. Kang, J. Kim, L.A. Lindsay, U. Roll, M. Knip et al. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD(65) and IA2 marks the early phases of autoimmune response in type 1 diabetes. J. Clin. Invest. 1996, 97: 2772-2783.
8. M. Aguilar-Diosdado, D. Parkinson, J. Corbett, G. Kwon, C.A. Marshall, R.L. Gingerich et al. Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes 1994, 43: 418-425.
9. B. Bergman and K. Haskins. Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes 1994, 43: 197-203.
10. J.S. Petersen, A.E. Karlsen, H. Markholst, A. Worsaae, T. Dyrberg and B. Michelsen. Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes 1994, 43: 1478-1484.
11. R. Tisch, R.S. Liblau, X.D. Yang, P. Liblau and H.O. McDevitt. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 1998, 47: 894-899.
12. D. Daniel and D.R. Wegmann. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B (9-23). PNAS USA 1996, 93: 956-960.
13. J.P. Mordes, B. Schirf, D. Roipko, D.L. Greiner, H. Weiner, P Nelson et al. Oral insulin does not prevent insulin-dependent diabetes mellitus in BB rats. Ann. N. Y. Acad. Sci. 1996, 778: 418-421.
14. J.S. Petersen, P. Mackay, A. Plesner, A. Karlsen, C. Gotfredsen, S. Verland et al. Treatment with GAD65 or BSA does not protect against diabetes in BB rats. Autoimmunity 1997, 25: 129-138.
15. P.A. Gottlieb, E.S. Handler, M.C. Appel, D.L. Greiner, J.P. Mordes and A.A. Rossini. Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB Wor rats. Diabetologia 1991, 34: 296-300.
16. S. Bieg, C. Moller, T. Olsson and Å. Lernmark. The lymphopenia (lyp) gene controls the intrathymic cytokine ratio in congenic BioBreeding rats. Diabetologia 1997, 40: 786-792.
17. M.J. Hegewald, S.L. Schoenfeld, D.K. McCulloch, C.J. Greenbaum, L.J. Klaff and J.P. Palmer. Increased specificity and sensitivity of insulin antibody measurements in autoimmune thyroid disease and type I diabetes. J. Immunol. Meth. 1992, 154: 61-68.
18. D.K. McCulloch, L.J. Klaff, S.E. Kahn, S.L. Schoenfeld, C.J. Greenbaum, R.S Mauseth et al. Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes 1990, 39: 549-556.
19. 3H recombinant human ligands. J. Immunol. Meth. 1995, 186: 89-99.
20. C.E. Grubin, T. Daniels, B. Toivola, M. Landin-Olsson, W. A. Hagopian, L. Li et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994, 37: 344-350.
21. A.E. Karlsen, W.A Hagopian, C.E. Grubin, S. Dube, C.M. Disteche, D.A. Adler, H. Bärmeier, S. Mathewes, F.J. Grant, D. Foster and Å. Lernmark. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. PNAS USA 1991, 88: 8337-8341.
22. B.K. Michelsen, J.S. Petersen, E. Boel, A. Møldrup, T. Dyrberg and O.D. Madsen. Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent mellitus. PNAS USA 1991, 88: 8754-8758.
23. A. Falorni, M. Ackefors, C. Carlberg, T. Daniels, B. Persson, J. Robertson et al. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia 1996, 39: 1091-1098.
24. M. Cetkovic-Cvrlje, I.C. Gerling, A. Muir, M.A. Elliot, E.H. Leiter. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta cell antigens. Diabetes 1997, 46: 1975-1982.
25. M. Ziegler, M. Schlosser, J. Hamann, P. Vieregge, F. Luhder, I. Kloting et al. Autoantibodies to glutamate decarboxylase detected in diabetes-prone BB/OK rats do not distinguish onset of diabetes. Exp. Clin. Endocrinol. 1994, 102: 98-103.
26. M.E. Elder and N.K. Maclaren. Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J. Immunol. 1983, 130: 1723-1731.
27. D.M. Cataldo and G.A. Van Nast. The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice. Vaccine 1997, 15: 1710-1715.
28. D.M. Granoff, Y.E. McHugh, H.V. Raff, A.S. Mokatrin and G.A. Van Nest. MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine. Infect. Immun. 1997, 65: 1710-1715.
29. D.A. Higgins, J.R. Carlson and G.A. VanNest. MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice. Vaccine 1996, 14: 478-484.
30. 2-terminal epitope in the autoantigen GAD65, distinguish Stiff-Man Syndrome from insulin-dependent diabetes mellitus. J. Exp. Med. 1994, 180: 595-606.
31. B.I. Durinovic, M. Hummel and A.G. Ziegler. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 1996, 45: 795-800.
32. L.C. Harrison, M.C. Honeyman, H.J. DeAizpurua, R.S. Schmidli, P.G. Colman, B.D. Tait et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993, 341: 1365-1369.
33. M.C. Honeyman, N. Stone, H.J. DeAizpurua, M.J. Rowley and L.C. Harrison. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes. J. Autoimmunity 1997, 10: 165-173.
34. M. Hummel, I. Durinovic-Bello and A.G. Ziegler. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. J. Autoimmunity 1996, 9: 427-430.
35. S. Bieg, E.M. Bailyes, N. Yassin, J. Amann, L. Herberg, A.M. McGregor et al. A multiplicity of protein antigens in subcellular fractions of rat insulinoma tissue are able to stimulate T cells obtained from non-obese diabetic mice. Diabetologia 1993, 36: 385-390.
36. B.M. Brooks-Worrell, G.A. Starkebaum, C. Greenbaum and J.P. Palmer. Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J. Immunol. 1996, 157: 5668-5674.